Veterinary Vaccine Market by Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, and Subunit and DNA Vaccines), by Animal Type (Companion (Equine, Canine, and Feline) and Livestock (Bovine, Ovine, Porcine, Poultry, and Others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 6,766.5 million in 2021, and is expected to exhibit a CAGR of 6.2% over the forecast period (2022-2028).
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
Currently, President Biden has announced that veterinary professionals and veterinary students are now permitted to administer shots in remote areas. APHIS, AHA, and USDA have deployed hundreds of employees to Nevada, Maryland, and Oklahoma to help with the vaccination effort. During the outbreak of COVID-19 in the U.S., these professionals are not allowed to be sued. Nevertheless, they have volunteered to serve in various roles to support vaccination programs in these states. Vaccines rarely produce sterilizing immunity, but they do exert strong selective pressure on pathogens.
Various key manufacturer such as Zoetis, Inc., Regeneron Pharmaceuticals, Boehringer Ingelheim, and Merck are focused on conducting research projects to understand the viral diseases, in order to develop vaccination, for efficiently treating animals from various diseases. For instance, Regeneron Pharmaceuticals, Inc. and Zoetis, Inc. in June 2018, entered into a five-year collaboration to research and develop new veterinary treatments by using Regeneron’s monoclonal antibody therapeutics in animals
Moreover, In January 2017, Boehringer Ingelheim and Merial officially merged, and have been going through integration since. With the inauguration of the new integrated R&D Center, the teams from both companies have now joined their forces in the R&D Center, which will leverage the broad R&D expertise to create powerful collaboration in veterinary R&D capabilities.
Furthermore, Boehringer Ingelheim, in May 2018 inaugurated its new integrated Asian Veterinary Research & Development Centre in China to enhance its research and innovation capacity.
Moreover, Aratana Therapeutics, Inc., AT-O14 Vaccine is under clinical trials for canine osteosarcoma, and similar vaccines in pipeline are expected to drive growth of the veterinary vaccine market over the forecast period.
Manufacturers are focused on adopting inorganic growth strategies such as acquisition to strengthen their market position is expected to drive growth of the market over the forecast period. For instance, in 2017, Merck Animal Health acquired Prondil S.A. Dedicated to the development of products for animal health care, particularly vaccines to local and international markets. This acquisition helped Merck to add comprehensive portfolio of vaccines for livestock into their existing product portfolio.
Request PDF Brochure with Latest Insights @
The global veterinary vaccine market is expected to exhibit a CAGR of 6.2% over the forecast period (2022-2028), owing to increasing number of R&D initiatives for veterinary vaccine and acquisitions by key players.
Among technology, inactivated vaccines segment is expected to account for a major revenue share by Inactivated vaccines contains killed pathogens, which cannot replicate and cause any disease.
Major players operating in the global veterinary vaccine market include Aratana Therapeutics, Inc., Regeneus Ltd., Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Zoetis, Inc., Eli Lilly and Company, Merck & Co., Inc. and Boehringer Ingelheim GmbH.
Reasons to buy this Veterinary Vaccine Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Veterinary Vaccine Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Veterinary Vaccine Market
◘ Leading company profiles reveal details of key Veterinary Vaccine Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Veterinary Vaccine Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Veterinary Vaccine Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Veterinary Vaccine Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Veterinary Vaccine Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Veterinary Vaccine Industry Impact
Chapter 2 Global Veterinary Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Veterinary Vaccine (Volume and Value) by Type
2.3 Global Veterinary Vaccine (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Veterinary Vaccine Sales, Consumption, Export, Import by Regions
Chapter 5 North America Veterinary Vaccine Market Analysis
Chapter 6 East Asia Veterinary Vaccine Market Analysis
Chapter 7 Europe Veterinary Vaccine Market Analysis
Chapter 8 South Asia Veterinary Vaccine Market Analysis
Chapter 9 Southeast Asia Veterinary Vaccine Market Analysis
Chapter 10 Middle East Veterinary Vaccine Market Analysis
Chapter 11 Africa Veterinary Vaccine Market Analysis
Chapter 12 Oceania Veterinary Vaccine Market Analysis
Chapter 13 South America Veterinary Vaccine Market Analysis
Chapter 14 Company Profiles and Key Figures in Veterinary Vaccine Business
Chapter 15 Global Veterinary Vaccine Market Forecast (2022-2028)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027